Preserved postischemic heart function in sucrose-fed type 2 diabetic OLETF rats

Life Sciences

Volumn 72, Issue 25, 2003, Pages 2839-2851

  Chen, Hong ^a,d   Higashino, Hideaki ^b   Kamenov, Zdravko A ^c   Azuma, Makiko ^b   Lee, Wen Hsiung ^b   Yang, Xiang Qun ^a   Zhou, Da Jin ^a   Yuan, Wen Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^d Shanghai Institute of Hypertension   (China)

Author keywords

Heart function; Hyperglycemia; Ischemia and reperfusion; Norepinephrine; Type 2 diabetes

Indexed keywords

DRINKING WATER; GLUCOSE; NORADRENALIN; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEMODYNAMICS; HYPERGLYCEMIA; ISOLATED HEART; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORADRENALIN RELEASE; NORADRENALIN URINE LEVEL; RAT; RAT STRAIN; SUGAR INTAKE; TISSUE REACTION;

EID: 0344406922     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00189-9     Document Type: Article

References (36)

1. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 48(5):1999;937-942.
2. Pyörälä K., Laakso M., Unsitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes/Metabolism Reviews. 3(2):1987;463-524.
3. Mahgoub M.A., Abd-Elfattah A.S. Diabetes mellitus and cardiac function. Molecular and Cellular Biochemistry. 180(1-2):1998;59-64.
4. Mizushige K., Yao L., Noma T., Kiyomoto H., Yu Y., Hosomi N., Ohmori K., Matsuo H. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 101(8):2000;899-907.
5. Kersten J.R., Toller W.G., Gross E.R., Pagel P.S., Warltier D.C. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. American Journal of Physiology Heart and Circulatory Physiology. 278(4):2000;H1218-H1224.
6. Meigs J.B., Singer D.E., Sullivan L.M., Dukes K.A., D'Agostino R.B., Nathan D.M., Wagner E.H., Kaplan S.H., Greenfield S. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. American Journal of Medicine. 102(1):1997;38-47.
7. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352(9131):1998;837-853.
8. Chen H., Azuma M., Maeda K., Kajimoto N., Higashino H. Impaired heart function and norepinephrine release after ischemia in stroke-prone spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology. 27(9):2000;664-670.
9. Remme W.J. The sympathetic nervous system and ischaemic heart disease. European Heart Journal. 19(Suppl. F):1998;F62-F71.
10. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., Natori T. Spontaneously long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 41(11):1992;1422-1428.
11. Nelissen-Vrancken H.J.M.G., Debets J.J.M., Snoeckx L.H.E.H., Daemen M.J.A.P., Smits J.F.M. Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Circulation. 93(2):1996;349-355.
12. Nakai T., Isobe K. Urinary and plasma catecholamine measurements by using high performance liquid chromatography. Medical Techniques. 18(2):1990;365-370.
13. 2+ channels. The Journal of Pharmacology and Experimental Therapeutics. 269(1):1994;221-229.
14. Feuvray D., Lopaschuk G.D. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovascular Research. 34(1):1997;113-120.
15. Moon C.H., Jung Y.S., Lee S.H., Baik E.J. Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury. Jpn. J. Physiol. 49(5):1999;409-415.
16. Bristow M.R. β-Adrenergic receptor blockade in chronic heart failure. Circulation. 101(5):2000;558-569.
17. Daly P.A., Sole M.J. Myocardial catecholamines and the pathophysiology of heart failure. Circulation. 82(2 Suppl.):1990;I35-I43.
18. Schmid H., Forman L.A., Cao X., Sherman P.S., Stevens M.J. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes. 48(3):1999;603-608.
19. Tamura K., Utsunomiya K., Nakatani Y., Saika Y., Onishi S., Iwasaka T. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus. European Journal of Nuclear Medicine. 26(10):1999;1310-1316.
20. Togane Y. Evaluation of the cardiac autonomic nervous system in spontaneously non-insulin-dependent diabetic rats by 123I-metaiodobenzylguanidine imaging. Annals of Nuclear Medicine. 13(1):1999;19-26.
21. Hadour G., Ferrera R., Sebbag L., Forrat R., Delaye J., de Lorgeril M. Improved myocardial tolerance to ischaemia in the diabetic rabbit. Journal of Molecular and Cellular Cardiology. 30(9):1998;1869-1875.
22. Schömig A., Fischer S., Kurz T., Richardt G., Schömig E. Nonexocytotic release of endogenous norepinephrine in the ischemic and anoxic rat heart: mechanism and metabolic requirements. Circulation Research. 60(2):1987;194-205.
23. Chen H., Higashino H., Maeda K., Zhang Z., Ohta Y., Wang Z., Su D.F., Yuan W.J. Reduction of cardiac norepinephrine improves postischemic heart function in stroke-prone spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. 38(6):2001;821-832.
24. 2-adrenergic receptors in the coronary microcirculation. Circulation. 84(5):1991;2108-2122.
25. Eberli F.R., Weinberg E.O., Grice W.N., Horowitz G.L., Apstein C.S. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circulation Research. 68(2):1991;466-481.
26. McNulty P.H., Jagasia D., Cline G.W., Ng C.K., Whiting J.M., Garg P., Shulman G.I., Soufer R. Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited-duration coronary occlusion. Circulation. 101(8):2000;917-922.
27. Vanoverschelde J.L., Janier M.F., Bakke J.E., Marshall D.R., Bergmann S.R. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery during reperfusion. American Journal of Physiology Heart and Circulatory Physiology. 267(5 Pt 2):1994;H1785-H1794.
28. Kraft S.A., Larson C.P. Jr., Shuer L.M., Steinberg G.K., Benson G.V., Pearl R.G. Effect of hyperglycemia on neuronal changes in a rabbit model of focal cerebral ischemia. Stroke. 21(3):1990;447-450.
29. Malmberg K., Rydén L., Hamsten A., Herlitz J., Waldenström A., Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. European Heart Journal. 17(9):1996;1337-1344.
30. Ramasamy R., Hwang Y.C., Whang J., Bergmann S.R. Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4. American Journal of Physiology Heart and Circulatory Physiology. 281(1):2001;H290-H297.
31. Beatch G.N., McNeill J.H. Ventricular arrhythmias following coronary artery occlusion in the streptozotocin diabetic rat. Canadian Journal of Physiology and Pharmacology. 66(4):1988;312-317.
32. Hekimian G., Khandoudi N., Feuvray D., Beigelman P.M. Abnormal cardiac rhythm in diabetic rats. Life Sciences. 37(6):1985;547-551.
33. Kusama Y., Hearse D.J., Avkiran M. Diabetes and susceptibility to reperfusion-induced ventricular arrhythmias. Journal of Molecular and Cellular Cardiology. 24(4):1992;411-421.
34. Curtis M.J., Pugsley M.K., Walker M.J.A. Endogenous chemical mediators of ventricular arrhythmias in ischemic heart disease. Cardiovascular Research. 27(5):1993;703-719.
35. Michaelis O.E. 4th, Velasquez M.T., Abraham A.A., Servetnick D.A., Scholfield D.J., Hansen C.T. Development and characteristics of a new strain of obese hyperinsulinemic and hyperlipidemic Dahl salt-sensitive rat. The Dahl salt-sensitive/NIH-corpulent rat. American Journal of Hypertension. 8(5 Pt 1):1995;467-473.
36. Ravingerova T., Styk J., Pancza D., Tribulova N., Sebokova J., Volkovova K., Ziegelhoffer A., Slezak J. Diabetic cardiomyopathy in rats: alleviation of myocardial dysfunction caused by calcium overload. Diabetes Research and Clinical Practice. 31 Suppl. 1996;S105-S112.